BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38093294)

  • 1. Efficacy and safety of oral Chinese patent medicines in the treatment of coronary heart disease combined with hyperlipidemia: a systematic review and network meta-analysis of 78 trials.
    Yang Z; Li J; Zhou B; Ji X; Yuan J; Yan J; Nan X; Guo D
    Chin Med; 2023 Dec; 18(1):162. PubMed ID: 38093294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Network Meta-analysis of oral Chinese patent medicines in treating type 2 diabetes mellitus complicated with angina pectoris of coronary heart disease].
    Zhang XM; Zhao XX; Liu Y; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):5078-5090. PubMed ID: 37802850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Network Meta-analysis of Chinese patent medicines in treatment of coronary heart disease complicated with heart failure].
    Wang AL; Wei JJ; Sun Y; Guo HX; Zhang MJ; Lu JF; Zhang YL; Peng GC; Zhu MJ
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):518-533. PubMed ID: 38403327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Network Meta-analysis of Chinese patent medicine in treatment of unstable angina pectoris].
    Zhang LM; DU TH; Niu LL; Wang LY; Li JN; Ma PF; Yu R
    Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(3):703-711. PubMed ID: 33645038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Network Meta-analysis of efficacy and safety of oral Chinese patent medicines combined with conventional western medicine in treatment of hypertension].
    Ji ZC; Lin SS; Hu HY; Sheng XD; Yang FW; Wang XL
    Zhongguo Zhong Yao Za Zhi; 2022 Apr; 47(7):1955-1988. PubMed ID: 35534266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Oral Chinese Patent Medicine Combined with Conventional Therapy for Heart Failure: An Overview of Systematic Reviews.
    Lin SS; Liu CX; Zhang JH; Wang XL; Mao JY
    Evid Based Complement Alternat Med; 2020; 2020():8620186. PubMed ID: 32908572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Network Meta-analysis of Chinese patent medicine containing Hirudo in treatment of atherosclerosis].
    Han QQ; Wen ZY; Lyu Q; Pan YY
    Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(1):234-246. PubMed ID: 36725276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Network Meta-analysis of oral or nasal feeding with Chinese patent medicine in treatment of hypertensive intracerebral hemorrhage].
    Lei L; Jia M; Liao X; Lu Y; Zhang YL; Liang X; Chen Q; Fu GJ
    Zhongguo Zhong Yao Za Zhi; 2021 Jun; 46(12):2995-3006. PubMed ID: 34467689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tongxinluo Capsule Combined with Atorvastatin for Coronary Heart Disease: A Systematic Review and Meta-Analysis.
    Liu Q; Dong T; Xi M; Gou L; Bai Y; Hou L; Li M; Ou L; Miao F; Wei P
    Evid Based Complement Alternat Med; 2021; 2021():9413704. PubMed ID: 34335841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory patterns of Chinese patent medicine for lipid metabolism disorders in patients with type 2 diabetes mellitus complicated by ischemic stroke: A systematic review and network meta-analysis.
    Lu Z; Zhang X; Xie Y
    Medicine (Baltimore); 2024 May; 103(20):e35050. PubMed ID: 38758863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Network Meta-analysis of Qi-supplementing and Yin-nourishing Chinese patent medicines in treatment of early diabetic nephropathy].
    Wang WR; Zhang XM; Li JX; Yang JY; Yu RH; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(14):3949-3964. PubMed ID: 37475086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Network Meta-analysis of efficacy and safety of Chinese patent medicines in treatment of insomnia].
    Shi ML; Zhao M; Wang YH; Sun TY; Li XL; Ren F; Bian SB; Cui ZH; Li SS
    Zhongguo Zhong Yao Za Zhi; 2021 Oct; 46(20):5403-5417. PubMed ID: 34738444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral proprietary Chinese medicine for lupus nephritis: A bayesian network meta-analysis.
    Lin A; Zhang Z; Liu X; Wu J
    Heliyon; 2023 Aug; 9(8):e18711. PubMed ID: 37593598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The comparative effects of oral Chinese patent medicines combined with western medicine in stable angina: A systematic review and network meta-analysis of 179 trials.
    Huang P; Li Z; Chen L; Zeng J; Zhao S; Tang Y; Huang B; Guan H; Chen Y; Feng Y; Lei S; Wu Q; Zhang H; Huang X; Zeng L; Liu Y; Zeng Z; Chen B
    Front Pharmacol; 2022; 13():918689. PubMed ID: 36059992
    [No Abstract]   [Full Text] [Related]  

  • 16. [Network Meta-analysis of Chinese patent medicines of Ziziphi Spinosae Semen in treatment of primary insomnia].
    Yao WQ; Zhao YH; Zheng YW; Zhang Q; Han X
    Zhongguo Zhong Yao Za Zhi; 2021 Sep; 46(17):4541-4554. PubMed ID: 34581060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Network Meta-analysis of oral Chinese patent medicine in treatment of migraine].
    Min J; Yan LU; Yun-Ling Z; Xing L; Xiao L; Wei S; Jing-Jing W; Lin L; Qian C; Guo-Jing FU
    Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(21):5068-5082. PubMed ID: 33350222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Network Meta-analysis of oral Chinese patent medicine in treatment of acute cerebral infarction].
    Cui RZ; Yu DD; Li HM; Hu RX; Zhao H; Liao X
    Zhongguo Zhong Yao Za Zhi; 2020 Jun; 45(11):2642-2657. PubMed ID: 32627500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese patent medicines combined with hormone replacement therapy for premature ovarian failure: A Bayesian network meta-analysis.
    Zhong HZ; Li MY; Yin XL; Bin CL; Zhou SY; Wei SB
    Front Med (Lausanne); 2022; 9():1043390. PubMed ID: 36465907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of different Chinese patent medicines in preventing restenosis after percutaneous coronary intervention: a systematic review and Bayesian network meta-analysis of randomized clinical trials.
    Fan J; Li T; Pu F; Guo N; Wang J; Gao Y; Zhao H; Wang X; Zhu H
    Front Pharmacol; 2023; 14():1265766. PubMed ID: 38249344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.